J. Safra Sarasin Holding AG lowered its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 17.6% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 113,692 shares of the conglomerate’s stock after selling 24,228 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Danaher were worth $21,518,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Sivia Capital Partners LLC raised its stake in shares of Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares during the last quarter. First Trust Advisors LP boosted its position in Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after buying an additional 14,217 shares during the last quarter. Main Street Financial Solutions LLC increased its holdings in Danaher by 40.2% in the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after buying an additional 886 shares during the period. Ieq Capital LLC increased its holdings in Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after buying an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC raised its position in Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after buying an additional 325 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Trading Up 0.0%
Danaher stock opened at $199.11 on Monday. The firm has a market cap of $140.92 billion, a PE ratio of 38.51, a P/E/G ratio of 2.54 and a beta of 0.79. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The stock’s 50 day simple moving average is $180.59 and its two-hundred day simple moving average is $199.27. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s payout ratio is presently 30.95%.
Analyst Ratings Changes
Several brokerages have commented on DHR. Barclays decreased their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Guggenheim reduced their target price on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Wells Fargo & Company lowered their price target on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 22nd. Finally, Citigroup began coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $231.64.
View Our Latest Stock Analysis on Danaher
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
